S. Wen

发表

Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes.

P. Hwu, R. Kurzrock, F. Janku, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGs.

R. Kurzrock, A. Naing, J. Aaron, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Personalized medicine in a phase I clinical trials program: The M. D. Anderson Cancer Center Initiative.

R. Kurzrock, F. Janku, A. Naing, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer

V. Baladandayuthapani, C. Garrett, S. Wen, 2012, British Journal of Cancer.

Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix.

R. Wolff, M. Overman, K. Fournier, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine

S. Kopetz, R. Wolff, M. Overman, 2009, British Journal of Cancer.

A retrospective analysis of 140 patients with giant cell tumor in the extremity: a multicenter study based on four hospitals in South China.

Bin Yu, N. Jiang, Cheng-he Qin, 2013, Cancer epidemiology.

Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix.

R. Wolff, M. Overman, K. Fournier, 2012 .

Assessment of needs, health-related quality of life, and satisfaction with care in breast cancer patients to better target supportive care

P. Hwu, F. Janku, A. Naing, 2013 .

Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience.

R. Kurzrock, A. Naing, D. Hong, 2012 .

Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience.

R. Kurzrock, A. Naing, D. Hong, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Survival advantage associated with metformin usage in patients with colorectal cancer (CRC) and type II noninsulin-dependent diabetes (NIDDM).

S. Kopetz, C. Garrett, C. Eng, 2011, Journal of Clinical Oncology.